Try our beta test site
2 studies found for:    9635529 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Establishing an Inflammatory Breast Cancer Registry
Condition: Inflammatory Breast Cancer
2 Suspended Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Conditions: HER2-negative Breast Cancer;   Inflammatory Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: Romidepsin;   Drug: Abraxane

Study has passed its completion date and status has not been verified in more than two years.